Clinical trial
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart…
NCT02675114 · Edwards Lifesciences, Industry · Active, not recruiting
Key facts
| NCT number | NCT02675114 |
|---|---|
| Title | PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis |
| Official title | A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement |
| Acronym | P3 |
| Lead sponsor | Edwards Lifesciences, Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Aortic Stenosis |
| Intervention type | Device, Procedure |
| Interventions | SAVR, SAPIEN 3 THV |
| Enrollment | 1,000 |
| Start date | Mar 1, 2016 |
| Primary completion | Nov 16, 2020 |
| Completion | Dec 1, 2029 |
| First posted | Feb 5, 2016 |
| Last update posted | Jan 14, 2026 |
| Countries | Australia, Canada, Japan, New Zealand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: